US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Horizon Kinetics Blockchain Development ETF

32.42

+0.26630.83%

Volume:288

Turnover:9K

Market Cap:23.50M

PE:- -

High:32.42

Open:32.41

Low:32.41

Close:32.15

52wk High:36.27

52wk Low:29.01

Shares:725.00K

Float Shares:725.00K

Volume Ratio:0.15

T/O Rate:0.04%

Dividend:0.76

Dividend Rate:2.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Climb Bio to Present Preliminary Phase 2 PrisMN Trial Data for Budoprutug in Primary Membranous Nephropathy at ASN Kidney Week 2026

Matador Technologies Calls Shareholder Meeting

Newcleo Names Ex-TVA Chief Jeffrey Lyash Board Chairman

Vera Therapeutics Says Origin 3 Final Efficacy Data for Trutakna in IgA Nephropathy is Set for Late-Breaking ASN Kidney Week 2026 Talk

Decent Holding Prices Private Placement of Unregistered Warrants for 822,828 Shares at $1.50 Each

Christian Dior Reports 180,507,516 Issued Shares as of Sept. 30, 2026

Artiva Biotherapeutics Posts Updated Phase 2a AlloNK Plus Rituximab Data in Refractory Rheumatoid Arthritis at ACR 2026

iTonic Holdings Announces 16-for-1 Share Consolidation Effective Oct. 6

Immuneering Plans Phase 2 Trial of Atebimetinib Plus PD-1 Blockade in Lung Cancer Patients

ATA Creativity Global Gets NASDAQ Notice After ADS Bid Price Stays Below $1

ProKidney Posts Pooled Phase 2 Data Showing Rilparencel Stabilizes Kidney Function in Advanced CKD with Diabetes

Cuprina to Buy Singapore Healthcare Group East Coast Podiatry and Orchard Clinic for S$4 Million

Evaxion to Present New Phase 2 Immune Data for EVX-01 Melanoma Vaccine at SITC 2026

Candel Therapeutics to Present NSCLC Aglatimagene Besadenovec Study Data at SITC 2026

MiNK Therapeutics Highlights Phase 2 Trial Testing agenT-797 with Botensilimab and Balstilimab in MSS Colorectal Cancer Liver Metastases

Orbit International Secures New $6 Million Revolving Credit Facility with Merchant Financial

BofA Securities Adjusts Intercontinental Exchange Price Target to $236 From $232, Maintains Buy Rating

MT Newswires Live

StoneX Agrees to Buy Colombia Coffee Trader Integra Trading

BofA Securities Adjusts Cboe Global Markets Price Target to $332 From $356, Maintains Neutral Rating

MT Newswires Live

20/20 BioLabs to Attend Maxim Growth Summit 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BCDF/news?page=51"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BCDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","market":"US","secType":"STK","nameCN":"Horizon Kinetics Blockchain Development ETF","latestPrice":32.4203,"timestamp":1791576000000,"preClose":32.154,"halted":0,"volume":288,"delay":0,"changeRate":0.00828201778938838,"floatShares":725000,"shares":725000,"eps":0,"marketStatus":"Market Closed","change":0.2663,"latestTime":"10-09 16:00:00 EDT","open":32.405,"high":32.4203,"low":32.405,"amount":9329,"amplitude":0.000476,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":32.154,"sharesOutstanding":675000,"nav":32.09,"aum":23265250,"dividendRate":0.023565,"bidAskSpread":0,"volumeRatio":0.153158917022232},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","floatShares":725000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.153158917022232,"shares":725000,"dividePrice":0.764,"high":32.4203,"amplitude":0.000476,"preClose":32.154,"low":32.405,"week52Low":29.01,"pbRate":"--","week52High":36.27,"institutionHeld":0,"latestPrice":32.4203,"eps":0,"divideRate":0.023565,"volume":288,"delay":0,"ttmEps":0,"open":32.405,"prevYearClose":30.2172,"prevWeekClose":31.9937,"prevMonthClose":32.0003,"prevQuarterClose":32.0003,"fiveDayClose":31.9937,"twentyDayClose":33.1605,"sixtyDayClose":31.6148},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCDF\",params:#limit:5,,,undefined,":[{"date":"2024-12-24","symbol":"BCDF","amount":0.45302,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"Horizon Kinetics Blockchain Development ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"BCDF","amount":0.169967,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"},{"market":"US","date":"2022-12-28","symbol":"BCDF","amount":0.05244,"defaultRemindTime":1672237800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2022-09-28","symbol":"BCDF","amount":0.0219,"defaultRemindTime":1664371800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-09-30","payableDate":"2022-09-29","currency":"USD","type":"dividend","dateTimestamp":1664337600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCDF\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-28","recordDate":"2022-09-29","paymentDate":"2022-09-30","value":0.0219,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.05244,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.169967,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.45302,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCDF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCDF\",pageSize:20,pageCount:51,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672712067","title":"Climb Bio to Present Preliminary Phase 2 PrisMN Trial Data for Budoprutug in Primary Membranous Nephropathy at ASN Kidney Week 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712067","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712067?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:30","pubTimestamp":1790947822,"startTime":"0","endTime":"0","summary":"Climb Bio to present preliminary Phase 2 PrisMN trial data for budoprutug in primary membranous nephropathy at ASN Kidney Week 2026Climb Bio flagged new clinical updates for CLYM116 and budoprutug ahe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL3hhf87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BCDF","BK4539","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","BK4139","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","NDAQ","CLYM","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672871206","title":"Matador Technologies Calls Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2672871206","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672871206?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:30","pubTimestamp":1790947813,"startTime":"0","endTime":"0","summary":"Matador Technologies calls shareholder meetingMatador Technologies will hold its annual general and special meeting in Toronto on Oct. 14, 2026.Shareholders will vote on a proposed amendment to create","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8QlsfF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","IE00B64PRP62.GBP","BK4588","BK4112","IE00BQXX3C00.GBP","BCDF","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","SG9999014021.USD","IE00BGHQF748.EUR","BK4585","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","NDAQ","IE00BN0W2V16.EUR","LU2210150020.SGD","SG9999014013.SGD","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672871279","title":"Newcleo Names Ex-TVA Chief Jeffrey Lyash Board Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2672871279","media":"Reuters","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672871279?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:27","pubTimestamp":1790947638,"startTime":"0","endTime":"0","summary":"Newcleo names ex-TVA chief Jeffrey Lyash board chairmanNewcleo named former Tennessee Valley Authority CEO Jeffrey Lyash as board chairman, bringing 40 years of power-sector engineering and operations","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL1DxWd1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","SG9999014021.USD","LU2095319765.USD","BK4588","IE00BQXX3C00.GBP","LU2210150020.SGD","LU0314104364.USD","BCDF","IE00BN0W2T93.GBP","SG9999014005.SGD","BK4585","BK4112","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","TVC","NWCL","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712271","title":"Vera Therapeutics Says Origin 3 Final Efficacy Data for Trutakna in IgA Nephropathy is Set for Late-Breaking ASN Kidney Week 2026 Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712271","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712271?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:24","pubTimestamp":1790947481,"startTime":"0","endTime":"0","summary":"Vera Therapeutics says ORIGIN 3 final efficacy data for TRUTAKNA in IgA nephropathy is set for late-breaking ASN Kidney Week 2026 talkVera Therapeutics flagged final efficacy results from the Phase 3 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7dZbDS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDF","BK4585","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","BK4539","BK4588","LU2210150020.SGD","BK4112","LU2324357040.USD","IE00BQXX3C00.GBP","NDAQ","LU0314104364.USD","SG9999014013.SGD","VERA","IE00BQXX3F31.USD","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712402","title":"Decent Holding Prices Private Placement of Unregistered Warrants for 822,828 Shares at $1.50 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712402","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712402?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:20","pubTimestamp":1790947219,"startTime":"0","endTime":"0","summary":"Decent Holding prices private placement of unregistered warrants for 822,828 shares at $1.50 eachDecent Holding priced a concurrent private placement of unregistered warrants to buy 822,828 Class A or","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL40K45F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","BK4120","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BQXX3F31.USD","SG9999014013.SGD","LU0314104364.USD","DXST","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4588","SG9999014005.SGD","BCDF","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672671291","title":"Christian Dior Reports 180,507,516 Issued Shares as of Sept. 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672671291","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672671291?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:14","pubTimestamp":1790946898,"startTime":"0","endTime":"0","summary":"Christian Dior reports 180,507,516 issued shares as of Sept. 30, 2026Christian Dior reported 180,507,516 issued shares as of Sept. 30, 2026.Gross voting rights totaled 356,941,538.Net voting rights st","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL1zXW7S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","BK4112","BCDF","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672125177","title":"Artiva Biotherapeutics Posts Updated Phase 2a AlloNK Plus Rituximab Data in Refractory Rheumatoid Arthritis at ACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672125177","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672125177?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:05","pubTimestamp":1790946328,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics posts updated Phase 2a AlloNK plus rituximab data in refractory rheumatoid arthritis at ACR 2026Artiva Biotherapeutics flagged updated Phase 2a basket-trial results for AlloNK w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL5PDSjG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","BK4139","IE00BN0W2V16.EUR","BK4588","NDAQ","IE00BQXX3F31.USD","BK4585","LU2210150020.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014005.SGD","SG9999014021.USD","IE00BGHQF748.EUR","ARTV","BCDF","LU2095319765.USD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712342","title":"iTonic Holdings Announces 16-for-1 Share Consolidation Effective Oct. 6","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712342","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712342?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946114,"startTime":"0","endTime":"0","summary":"iTonic Holdings announces 16-for-1 share consolidation effective Oct. 6iTonic will execute a 16-for-1 share consolidation effective 12:01 a.m. ET on Oct. 6, 2026.Nasdaq trading is expected to begin on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL9qRmPl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","ITOC","IE00BQXX3C00.GBP","SG9999014013.SGD","LU2095319765.USD","SG9999014021.USD","BK4588","BK4585","IE00B3QW5Z07.USD","BCDF","IE00BN0W2V16.EUR","NDAQ","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","LU0314104364.USD","BK4167","LU2210150020.SGD","IE00BQXX3F31.USD","SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672171234","title":"Immuneering Plans Phase 2 Trial of Atebimetinib Plus PD-1 Blockade in Lung Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2672171234","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672171234?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946113,"startTime":"0","endTime":"0","summary":"Immuneering plans Phase 2 trial of atebimetinib plus PD-1 blockade in lung cancer patientsImmuneering flagged preclinical results showing atebimetinib can strengthen PD-1 checkpoint blockade in RAS-mu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL50ZKvy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","BK4588","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BKPKM429.USD","BK4585","BK4539","LU2095319765.USD","BK4112","BK4139","IE00B64PRP62.GBP","BK4563","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","NDAQ","IE00BQXX3F31.USD","LU2210149790.SGD","IMRX","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712312","title":"ATA Creativity Global Gets NASDAQ Notice After ADS Bid Price Stays Below $1","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712312","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712312?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946089,"startTime":"0","endTime":"0","summary":"ATA Creativity Global gets Nasdaq notice after ADS bid price stays below $1Nasdaq issued a bid-price deficiency notice to ATA Creativity Global after its ADS bid stayed below $1.00 for 31 straight bus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8msm60:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","IE00BQXX3C00.GBP","LU2210150020.SGD","BK4588","AACG","LU2210149790.SGD","BK4204","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712346","title":"ProKidney Posts Pooled Phase 2 Data Showing Rilparencel Stabilizes Kidney Function in Advanced CKD with Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712346?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946087,"startTime":"0","endTime":"0","summary":"ProKidney posts pooled Phase 2 data showing rilparencel stabilizes kidney function in advanced CKD with diabetesProKidney flagged a new pooled Phase 2 analysis in advanced CKD with type 2 diabetes, wi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7TJRHh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","BCDF","NDAQ","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4585","BK4139","IE00BQXX3F31.USD","SG9999014021.USD","LU2095319765.USD","IE00BQXX3D17.EUR","PROK","SG9999014013.SGD","IE00BN0W2W23.USD","LU0314104364.USD","LU2210149790.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712344","title":"Cuprina to Buy Singapore Healthcare Group East Coast Podiatry and Orchard Clinic for S$4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712344","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712344?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946067,"startTime":"0","endTime":"0","summary":"Cuprina to buy Singapore healthcare group East Coast Podiatry and Orchard Clinic for S$4 millionCuprina entered SPAs to buy 100% of Singapore’s East Coast Podiatry and Orchard Clinic, totaling seven c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7M7xqN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4112","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","LU2210150020.SGD","BCDF","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","CUPR","LU0314104364.USD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BKPKM429.USD","NDAQ","IE00BQXX3F31.USD","BK4585","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672123457","title":"Evaxion to Present New Phase 2 Immune Data for EVX-01 Melanoma Vaccine at SITC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672123457","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672123457?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946062,"startTime":"0","endTime":"0","summary":"Evaxion to present new phase 2 immune data for EVX-01 melanoma vaccine at SITC 2026Evaxion flagged new immune data from its phase 2 EVX-01 personalized cancer vaccine study in advanced melanoma.Result","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL1vWkZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4588","NDAQ","SG9999014013.SGD","LU2210149790.SGD","EVAX","IE00BN0W2T93.GBP","BCDF","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014005.SGD","BK4112","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014021.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712822","title":"Candel Therapeutics to Present NSCLC Aglatimagene Besadenovec Study Data at SITC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712822","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712822?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:00","pubTimestamp":1790946058,"startTime":"0","endTime":"0","summary":"Candel Therapeutics to present NSCLC aglatimagene besadenovec study data at SITC 2026Candel Therapeutics set two poster presentations at SITC’s 41st Annual Meeting, November 4-8, 2026 in Phoenix.Resul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLfkxys:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","IE00B64PRP62.GBP","BK4588","BK4139","BK4112","IE00BQXX3C00.GBP","BCDF","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","SG9999014021.USD","IE00BGHQF748.EUR","BK4585","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","NDAQ","IE00BN0W2V16.EUR","BK4539","LU2210150020.SGD","SG9999014013.SGD","IE00BQXX3F31.USD","LU2095319765.USD","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712809","title":"MiNK Therapeutics Highlights Phase 2 Trial Testing agenT-797 with Botensilimab and Balstilimab in MSS Colorectal Cancer Liver Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712809","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712809?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:00","pubTimestamp":1790946035,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics highlights Phase 2 trial testing agenT-797 with botensilimab and balstilimab in MSS colorectal cancer liver metastasesMiNK Therapeutics flagged new preclinical data for agenT-797 in ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL5vdlDZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","INKT","LU2210149790.SGD","BK4139","IE00BQXX3C00.GBP","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","BCDF","NDAQ","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672207714","title":"Orbit International Secures New $6 Million Revolving Credit Facility with Merchant Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672207714","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672207714?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:45","pubTimestamp":1790945112,"startTime":"0","endTime":"0","summary":"Orbit International secures new $6 million revolving credit facility with Merchant FinancialOrbit International closed a new revolving line of credit of up to $6 million with Merchant Financial.About ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7RB4Qx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4211","ORBT","LU0314104364.USD","LU1668664300.SGD","LU0106831901.USD","BK4585","LU2095319765.USD","IE00BQXX3F31.USD","MTB","IE00BN0W2T93.GBP","IE00BKPKM429.USD","LU0053666078.USD","LU0738911758.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","SG9999014039.USD","LU0170899867.USD","SG9999014005.SGD","BK4112","LU0661504455.SGD","BK4588","BK4096","IE00BN0W2W23.USD","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2V16.EUR","LU0949170772.SGD","IE00B3QW5Z07.USD","BCDF","SG9999014013.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714137","title":"BofA Securities Adjusts Intercontinental Exchange Price Target to $236 From $232, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714137","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714137?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:37","pubTimestamp":1790944655,"startTime":"0","endTime":"0","summary":"Intercontinental Exchange (ICE) has an average rating of buy and mean price target of $186.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0738911758.USD","BCDF","LU1506573853.SGD","IE00BQXX3D17.EUR","LU0162691827.USD","ICE.AU","LU1363072403.SGD","LU0971096721.USD","LU0256863902.USD","SG9999004303.SGD","BK4588","LU0130102774.USD","ICE","LU2023250843.SGD","LU2023250504.SGD","LU1974910355.USD","LU0648001328.SGD","BK4585","LU0011850046.USD","LU2237957902.USD","LU0390134368.USD","BK4112","LU0314106906.USD","LU0477156953.USD","LU0124676726.USD","SGXZ23171101.USD","GB00BDT5M118.USD","IE00BQXX3C00.GBP","LU0417517546.SGD","LU2237957811.SGD","LU0072461881.USD","LU1153585028.USD","LU0980610538.SGD","LU0661504455.SGD","IE00BQXX3F31.USD","LU0154236417.USD","LU0256863811.USD","LU0130517989.USD","LU2106854487.HKD","LU0949170772.SGD","LU1201861249.SGD","BK7016","LU0154245673.USD","LU0154245756.USD","LU0689626769.HKD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714955","title":"StoneX Agrees to Buy Colombia Coffee Trader Integra Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714955","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714955?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:33","pubTimestamp":1790944398,"startTime":"0","endTime":"0","summary":"StoneX agrees to buy Colombia coffee trader Integra TradingStoneX agreed to buy Colombian coffee trader and processor Integra Trading to build an origination and milling platform in Colombia.Deal rout","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLVx2Lf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","BK4127","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014021.USD","LU2095319765.USD","LU2210149790.SGD","LU0566484027.USD","SG9999014013.SGD","LU1559883803.SGD","LU1815336091.USD","BK4585","BCDF","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SNEX","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU0757428866.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","BK4588","NDAQ","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672071498","title":"BofA Securities Adjusts Cboe Global Markets Price Target to $332 From $356, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672071498","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672071498?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:31","pubTimestamp":1790944318,"startTime":"0","endTime":"0","summary":"Cboe Global Markets (CBOE) has an average rating of hold and mean price target of $311.53, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","BK4112","CBOE","BCDF","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672271460","title":"20/20 BioLabs to Attend Maxim Growth Summit 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672271460","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672271460?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:31","pubTimestamp":1790944275,"startTime":"0","endTime":"0","summary":"20/20 BioLabs to Attend Maxim Growth Summit 202620/20 BioLabs will attend the Maxim Growth Summit 2026 on Oct. 13-14 in New York.Management will hold one-on-one meetings with institutional investors o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7mDVWl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","LU2210149790.SGD","IE00BQXX3F31.USD","SG9999014039.USD","SG9999014021.USD","AIDX","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014005.SGD","BK4588","LU2210150020.SGD","IE00BQXX3C00.GBP","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","BK4585","NDAQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":93,"pageCount":51,"totalSize":1857,"code":"91000000","status":"200"}]}}